通过16型但不包括11型的人类乳头瘤病毒DNA的依赖葡萄糖皮质激素的瘤转化
M M Pater1, G A Hughes, D E Hyslop
1Faculty of Medicine, Memorial University of Newfoundland, St. John's, Canada.
Nature
|October 27, 1988
概括
人类乳头瘤病毒 (HPV) 16型DNA,结合Ha-ras瘤基因和甲,可以在瘤学上转化原始细胞. 这表明荷尔蒙在与HPV相关的宫癌发育中的作用.
科学领域:
- 在瘤学瘤学.
- 病毒学 病毒学
- 分子生物学分子生物学
背景情况:
- 子宫状细胞癌是女性常见的癌症,与人类乳头瘤病毒 (HPV) 感染有很强的相关性.
- 综合性HPV型16和18DNA在大多数宫瘤中被发现.
- 激素和烟草被怀疑是子宫瘤的共因子,在HPV-16中发现了对葡萄糖皮质激素有反应的元素.
研究的目的:
- 研究HPV-16DNA与激活的Ha-ras瘤基因结合的瘤转化潜力.
- 确定葡萄糖皮质激素德克萨米他在这种转化过程中的作用.
主要方法:
- 原始细胞被感染了HPV-16DNA和一个激活的人类Ha-ras瘤基因.
- 评估了德克萨米他对瘤转化的影响.
主要成果:
- 当初级细胞同时暴露于HPV-16DNA,激活的Ha-ras和德克萨米他时,观察到致癌转化.
- 在相同的条件下,HPV-11 DNA没有诱导转变,这表明HPV类型的特异性.
- 德克萨米他对于观察到的瘤转变至关重要.
结论:
- 结合HPV-16DNA,激活的Ha-ras和德克萨米他可以诱导原始细胞的瘤转化.
- 葡萄糖皮质醇激素可能在与HPV相关的宫癌的发展中起到关键的辅助作用.
相关概念视频
Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Cancer-Critical Genes I: Proto-oncogenes
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Mechanisms of Retrovirus-induced Cancers
Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
Rous Sarcoma Virus (RSV) and Cancer
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Mechanisms of Retrovirus-induced Cancers
Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
Mutagenicity and Carcinogenicity
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...


